Dr. Jianqiang Tang 汤坚强
Chief Physician, Associate Professor
Department of Colorectal Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Open and laparoscopic surgery for gastrointestinal tumors, including sphincter-preserving procedures for low rectal cancer, radical colectomy, gastrectomy, and combined endoscopic-laparoscopic techniques.
Dr. Tang joined the Colorectal Surgery Department at the Cancer Hospital, Chinese Academy of Medical Sciences in September 2021 as Deputy Administrative Director. Previously an Associate Chief Physician at Peking University First Hospital, Dr. Tang earned a medical degree from Peking University in 2001 and a PhD in 2006. The doctor performs over 800 surgeries annually, with extensive experience in laparoscopic gastrointestinal tumor resections.
Professional roles
- Member, APELS (Asia-Pacific Endo-Laparoscopic Society)
- Member, Colorectal Surgery Branch, Chinese Medical Doctor Association
- Standing Committee Member, Rectal Cancer Prevention and Treatment Committee, China International Exchange and Promotion Association for Medical and Healthcare
- Member, Colorectal and Anal Surgery Committee, Chinese Research Hospital Association
Name order: in Chinese the family name comes first (Tang Jianqiang). Papers usually list the name as Jianqiang Tang or Tang J.
Selected publications
49 papers on PubMed matched by name and affiliation; 31 as first or senior author since 2016. Most recent first- or senior-author papers:
- Dis Colon Rectum, 2026 (senior author): Comparative Outcomes of CREATE Versus Conventional Double-Stapling Technique for Ultralow Rectal Cancer: A Multicenter Propensity-Matched Analysis. PubMed 43017865
- Clin Interv Aging, 2026 (senior author): Risk Factors for Severe Postoperative Complications After Laparoscopic Colorectal Cancer Surgery in Octogenarians: A Retrospective Cohort Study. PubMed 42078009
- Front Immunol, 2026 (senior author): Neoadjuvant chemoradiotherapy with or without PD-1 inhibitors in MMR-proficient non-metastatic rectal cancer: a meta-analysis of randomized controlled trials. PubMed 41853263
- J Cancer Res Clin Oncol, 2025 (senior author): Efficacy and safety of neoadjuvant therapy combined with immunotherapy in MMR‑proficient/microsatellite stable non‑metastatic rectal cancer: a systematic review and meta‑analysis. PubMed 41396282
- Updates Surg, 2025 (senior author): Reduction in anastomotic leakage by fluorescent laparoscopic resection for ultra-low rectal cancer: a propensity-matched analysis with BMI stratification. PubMed 41066064
- BMC Gastroenterol, 2025 (senior author): Neoadjuvant combination immunotherapy for colorectal cancer: clinical and molecular predictors of pathological complete response and safety assessment. PubMed 41152720
- Front Cell Dev Biol, 2025 (senior author): Comprehensive fragmentation of cell-free repetitive DNA for enhanced cancer detection in plasma. PubMed 40703650
- EBioMedicine, 2025 (senior author): A new EGFR and c-Met bispecific NIR-II fluorescent probe for visualising colorectal cancer and metastatic lymph nodes. PubMed 40250245
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion